Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2010
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/23/2010WO2010105930A1 Carbamate derivatives in particular for the treatment of neurological disorders
09/23/2010WO2010105772A1 Novel method for producing enaminocarbonyl compounds
09/23/2010US20100240915 Pre-Treatment of Crude Alcohol or Furan Feed to a Vapor Permeation Apparatus
09/23/2010US20100240911 Process for the preparation of N-monosubstituted beta-amino alcohols
09/23/2010US20100240879 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivates and intermediates therein
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240729 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same
09/23/2010US20100240725 Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240629 Polymorphs of fluticasone furoate and processes for preparation thereof
09/23/2010US20100239726 Method to selectively remove safrole from nutmeg oil
09/23/2010US20100236634 Method of Formation of Hydrate Particles in a Water-Containing Hydrocarbon Fluid Flow
09/22/2010EP2230236A1 New method for producing enaminocarbonyl compounds
09/22/2010EP1494995B1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
09/22/2010CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
09/22/2010CN101838279A Aliphatic dicarboxylic acid aluminum isopropoxide and preparation method and application thereof
09/22/2010CN101838253A Preparation method of ligustilide and butylidene phthalide
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010CA2545821C Aroylfuranes and aroylthiophenes
09/21/2010CA2451915C Crystalline composition containing escitalopram
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/16/2010WO2010104738A1 An improved process for reacting an a, b-unsaturated dicarboxylic acid compound with an ethylenically unsaturated hydrocarbon
09/16/2010WO2010104722A1 Production of formic acid
09/16/2010WO2010104194A1 Benzofuran derivatives
09/16/2010WO2010103976A1 Process for producing carboxylic anhydride, and arylboronic acid compound
09/16/2010WO2010103553A1 Process for the preparation of ramelteon
09/16/2010WO2010102848A1 Cyclopentadione derived herbicides
09/16/2010WO2010102758A2 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
09/16/2010US20100234622 Process for the preparation of ramelteon
09/16/2010US20100234621 Process for reacting an alpha, beta-unsaturated dicarboxylic acid compound with an ethylenically unsaturated hydrocarbon
09/16/2010US20100234550 High shear oxidation of wax
09/16/2010US20100234453 Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system
09/16/2010US20100234229 Substituted Spirocyclic Ketoenols
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/16/2010US20100233086 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
09/16/2010CA2754904A1 Benzofuran derivatives
09/16/2010CA2754847A1 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
09/16/2010CA2754802A1 Process for the preparation of ramelteon
09/16/2010CA2750446A1 Cyclopentadione derived herbicides
09/15/2010EP2228373A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T
09/15/2010EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
09/15/2010CN101835874A Luminescent-element material and luminescent element
09/15/2010CN101835770A Condensed compounds with activity at estrogen receptors
09/15/2010CN101835728A Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
09/15/2010CN101831486A Application of mycobacterium tuberculosis Rv1354c gene as medicament target
09/15/2010CN101830875A Anti-inflammatory compound inula lineariifolia lactone A and preparation method and application thereof
09/15/2010CN101830874A Preparation method of Xanthatin
09/15/2010CN101830873A Preparation method of 13-chloro-3,15-dicarbonyl gibberellic acid and salt thereof
09/15/2010CN101830872A Synthetic method of 3-hydroxyl benzofuran derivatives
09/15/2010CN101830871A New furan derivative and application thereof
09/15/2010CN101829602A Catalytic system for preparing N-Boc-aromatic amine compounds and preparation method and application thereof
09/15/2010CN101829593A Preparation method of titanium dioxide persulfate-loaded mordenite solid superacid catalyst
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795242 The antigens are associated with recognition of CD1 molecules by T cells. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of therapeutic and prophylactic applications
09/14/2010CA2509796C Process for modifying drug crystal formation
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2394276C Serine protease inhibitors
09/14/2010CA2314771C Method for manufacturing aminoalcohol
09/10/2010WO2010101024A1 Method for preparing 5-hydroxymethylfurfural
09/09/2010US20100228039 Ruthenium (ii) catalysts for use in stereoselective cyclopropanations
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100227902 Bis-aryl sulfonamides
09/09/2010US20100227892 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
09/08/2010EP2225200A1 Convergent synthesis of renin inhibitors and intermediates useful therein
09/08/2010EP1915357B1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
09/08/2010EP1773799B1 Process for the preparation of optically-active compounds
09/08/2010CN1935798B Method for preparing and rographalide
09/08/2010CN1886442B Pellicle and novel fluoropolymer
09/08/2010CN101827835A Process for the preparation of tetranorlabdane derivatives
09/08/2010CN101827834A Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group
09/08/2010CN101827833A Mixture of furfural and 5-(alkoxymethyl)furfural derivatives from sugars and alcohols
09/08/2010CN101827817A Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
09/08/2010CN101824014A Compounds with anti-tumor activity in chloranthus japonicus as well as effective parts and purpose thereof
09/08/2010CN101824013A Maraniol with anti-cancer activity and preparation method thereof
09/08/2010CN101824012A 2-(1,6,7,8-tetrahydrogen-2H-indeno-[5,4-b] furan-8-group) acetonitrile, preparation method and applciation
09/08/2010CN101824011A Method for preparing 3-O-alkyl ascorbic acid
09/08/2010CN101824010A Method for synthesizing 4-aryl-4,5-dihydrofuran
09/08/2010CN101822982A Catalyst for furan production by furfural liquid-phase decarbonylation, preparation method and application method thereof
09/07/2010US7790900 such as 1-amino-2-phenylpropane by reacting unsaturated nitroolefin with organosilicon compounds such as poly(methylhydrosiloxane) and phenylsilane, in presence of asymmetric copper complex having phosphine ligand
09/07/2010US7790811 Pellicle and novel fluoropolymer
09/07/2010US7790724 c-fms kinase inhibitors
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790708 Prodrugs of GABA analogs, compositions and uses thereof
09/07/2010US7790037 Separation of compounds using tagging moieties including varying numbers of repeat units
09/02/2010WO2010098193A1 β-AMINOCARBONYL COMPOUND MANUFACTURING METHOD AND LITHIUM BINAPHTHOLATE COMPLEXES
09/02/2010WO2010097374A1 Compounds for use as bradykinin b1 antagonists
09/02/2010US20100222603 Glyceryl Ether Compounds and their Use
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222380 Modified Chalcone Compounds as Antimitotic Agents
09/02/2010US20100222338 Beta-secretase modulators and methods of use
09/02/2010US20100222330 New Compounds
09/02/2010US20100221201 Organosiloxanes Containing Ester Derivatives Of Ascorbic Acid
09/02/2010US20100221186 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
09/02/2010US20100218416 Branched alcohol ethers, e.g. 5-hydroxymethylfurfural tert-butyl ether as biofuel or renewable fuel additive; blends with other biofuels, gasoline, or diesel; superior blending properties compared to ethers obtained from unbranched alcohol analogs
09/02/2010US20100218415 Hydroxymethylfurfural ethers from sugars and higher alcohols
09/01/2010EP2224013A1 Methods for the determination of telomerase activity using click chemistry
09/01/2010EP2223910A1 Oxime esters and photopolymerization initiators containing the same
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 472